Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

LIVER-TRANSPLANTATION - AN UNFINISHED PRODUCT TRANSPLANTATION PROCEEDINGS Starzl, T. E., Todo, S., Tzakis, A. G., Gordon, R. D., Makowka, L., Stieber, A., Podesta, L., Yanaga, K., Concepcion, W., Iwatsuki, S. 1989; 21 (1): 2197-2197

Abstract

Liver transplantation has become an extraordinarily valuable and useful operation, but one that is not perfect and that has not been exploited to anything like its full potential. Better immunosuppression may become available soon as exemplified by developments with the Japanese drug, FK506. Improved preservation with the UW solution is already here. With these advantages, liver transplantation is certain to become far more widely used than at any time in the past. Examples were cited of innovative approaches using liver transplantation for the treatment of hepatic malignancies.

View details for Web of Science ID A1989U152400390

View details for PubMedID 2469232